Laminar Pharma Company Profile, Contacts & Intelligence

Biotechnology ResearchCtra Valldemossa Km. 7, 4, Parcbit. Edif. 17 2º Piso39 employeesFounded 2006
3 contacts with email or phone data3 with email data
View verified contacts Compare competitors
Employees
39
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
1
Mapped contact coverage

Laminar Pharma Overview

Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the novel Membrane-Lipid Therapy (MLT) strategy, which targets membrane lipids and/or the structures they form, rather than directly targeting specific cellular proteins. MLT-based drugs specifically interact with and modulate the activity of key signal-transduction peripheral proteins involved in the pathogeny of serious diseases like cancer, CNS, inflammatory or metabolic diseases. Innovative MLT-based drugs will soon become reference treatments worldwide for serious diseases with important medical needs unmet, such as glioblastoma and other aggressive cancer malignancies, as well as neuro-degenerative, metabolic, cardiovascular or inflammatory diseases. These novel drugs will provide a safe and efficacious therapeutic alternative that will bring dramatic improvements in the clinical outcome and in the quality of life for an important number of patients with these pathologies.

Headquarters
Ctra Valldemossa Km. 7, 4, Parcbit. Edif. 17 2º Piso
Website
laminarpharma.com
Industry
Biotechnology Research
Founded
2006
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Design research and development of innovative molecules based on the novel therapeutic approach the Membrane Lipid Therapy (MLT)

Laminar Pharma Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
1 company-domain email
Visible contacts using Laminar Pharma's company email domain.
General
2

Laminar Pharma People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

S
Salvador Salas
E
D
David Roberto
Director Financiero En Laminar Pharma
E
J
Joe Dillon, Ph.d., Mba
CEO at Dillon Capital Strategies
E
F
Facundo Rua
Executive with Focus on Technology

Laminar Pharma Workforce Composition

Seniority breakdown across 11 visible profiles.

Individual contributor
6
Associate / junior
2
Executive
1
Director
1
Manager
1

Compare Similar Companies to Laminar Pharma

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
PharmaMar Biotechnology Research 460 View company
Roams Technology, Information And Media 95 View company
Labo'life España Pharmaceutical Manufacturing 45 View company
Neurologyca Science & Marketing Market Research 26 View company
Telum Therapeutics Biotechnology 21 View company
CIRCE Health Science Research Services 14 View company
Trimerbody Pharma Research 7 View company
BIOIB Biotechnology 6 View company
Ikan Biotech Biotechnology Research 4 View company
Neurofix Pharma S.A. Biotechnology Research 4 View company